Drugs / etericoxib
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05069311 | Oct 2021 → Mar 2022 | chronic pain syndrome, inflammatory disease | Udayana University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | etericoxib | “etericoxib 90 mg per oral give two-hours before surgery and then continued until three days post-surgery” NCT05069311 ↗ |
| Route | Oral | “per oral” NCT05069311 ↗ |